Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on July 15, 2021, covering events occurring on July 9, 2021. The filing addresses the status of the Company's 2021 Annual Meeting of Stockholders, which had been previously adjourned on May 13, 2021, and again on June 11, 2021.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
The primary material event reported is the reconvening of the 2021 Annual Meeting on July 9, 2021. The meeting was adjourned again because there was an insufficient number of shares present or represented by proxy to constitute a quorum. No changes were made to the proposals to be voted on by stockholders.
Guidance, Outlook, and Risks
The Company has scheduled the reconvened Annual Meeting for August 6, 2021, at 8:30 a.m. Pacific Time / 11:30 a.m. Eastern Time. The meeting will be held at the Company's offices in San Francisco, California. The record date for the meeting remains April 12, 2021. Stockholders who have already voted do not need to take further action unless they wish to change their vote. The filing references a press release (Exhibit 99.1) regarding the adjournment but notes that the press release is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Facts for Investor Verification
- The 2021 Annual Meeting failed to achieve quorum on July 9, 2021, and has been rescheduled for August 6, 2021.
- The record date for the meeting remains April 12, 2021.
- No changes have been made to the proposals originally presented in the Proxy Statement filed on April 13, 2021.
- Stockholders who previously submitted proxies do not need to take action unless they wish to change their vote.
- This filing contains no financial performance data or updated guidance.